These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5790193)

  • 41. [On the treatment of cerebral and peripheral arterial obliterating vascular disorders with Tebonin].
    Gau HP
    Arztl Forsch; 1969; 23(3):103-11. PubMed ID: 5819754
    [No Abstract]   [Full Text] [Related]  

  • 42. Obliterative arterial disease of the lower limbs. IV. Evaluation of long-term anticoagulant therapy.
    Tillgren C
    Acta Med Scand; 1965 Aug; 178(2):203-19. PubMed ID: 4158084
    [No Abstract]   [Full Text] [Related]  

  • 43. [The place of anticoagulants in the treatment of cerebral atherosclerosis].
    Mouren P; Tatossian A; Bille J
    Mars Med; 1965; 102(5):451-4. PubMed ID: 5889117
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-term effect of anticoagulants in obliterative arterial disease of the legs.
    Tillgren C; Lund F
    Scand J Clin Lab Invest Suppl; 1967; 99():184-6. PubMed ID: 6056920
    [No Abstract]   [Full Text] [Related]  

  • 45. [Problems in the use of anticoagulants in severe arterial occlusive diseases of the limbs].
    Linke H
    Z Gesamte Inn Med; 1970 Aug; 25(15):688-93. PubMed ID: 5527533
    [No Abstract]   [Full Text] [Related]  

  • 46. Fibrinolytic activity and the effects of beta-pyridylcarbinol (Ronicol) in patients with arteriosclerosis obliterans.
    Grodzińska L; Basista M; Kedzior A; Korbut R; Kostka-Trabka E; Gryglewski R
    Thromb Haemost; 1983 Dec; 50(4):797-9. PubMed ID: 6364447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Conservative treatment of arteriosclerosis obliterans of the lower limbs].
    Kancelarczyk WL; Rymaszewski Z
    Kardiol Pol; 1981; 24(8):571-7. PubMed ID: 6169868
    [No Abstract]   [Full Text] [Related]  

  • 48. [Fibrinolysis in arteriosclerosis obliterans of the lower extremities].
    GIBINSKI K; NOWAK A
    Pol Arch Med Wewn; 1961; 31():309-15. PubMed ID: 13705097
    [No Abstract]   [Full Text] [Related]  

  • 49. [Medical therapy of obliterating arteriosclerosis of the lower extremities].
    MILANES B; CARRILLO RIERA P; PEREZ M
    Angiologia; 1958; 10(3):142-50. PubMed ID: 13533934
    [No Abstract]   [Full Text] [Related]  

  • 50. [Electroencephalographic and audiometric controls in presenile and senile arteriosclerotic subjects treated with an extractive sulfomucopolysaccharide complex with fibrinolytic action].
    Sfondrini E; Barberi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5082-6. PubMed ID: 4188593
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of various drugs on the dynamics of fibrinolysis in humans].
    Brunetti S; Tesi M
    Riv Crit Clin Med; 1967 Aug; 67(3):233-45. PubMed ID: 5633715
    [No Abstract]   [Full Text] [Related]  

  • 52. Atherosclerosis. A personal overview.
    Page IH
    Circulation; 1968 Dec; 38(6):1164-72. PubMed ID: 5721966
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of acute arterial occlusion].
    Schnell D
    Ther Ggw; 1966 Aug; 105(8):1002-5. PubMed ID: 5921256
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of the fibrinolytic system in experimental atheromatosis].
    Lasierra J; Díez MM; Capetillo MA; Viladés E; Gracia A; Aznar López J; Piñero J; López Campos JL; Bermudo F; Cobo R
    Sangre (Barc); 1982; 27(6):1018-29. PubMed ID: 6764034
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of low-molecular dextran on plasma cholesterol level in patients with arteriosclerosis].
    Himmel A; Tkaczewski W; Walasek L
    Pol Tyg Lek; 1970 Jan; 25(2):43-5. PubMed ID: 5415359
    [No Abstract]   [Full Text] [Related]  

  • 56. Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas.
    Wissler RW; Vesselinovitch D
    Appl Pathol; 1983; 1(2):89-96. PubMed ID: 6678159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Conservative treatment of chronic peripheral arterial occlusive diseases].
    Donat K; Klempien EJ; Scheppokat KD
    Med Klin; 1966 Feb; 61(6):216-20. PubMed ID: 5982913
    [No Abstract]   [Full Text] [Related]  

  • 58. Lipid lowering therapy in atherosclerosis.
    Aikawa M; Libby P
    Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of obliterating arteriosis].
    Skripnichenko DF
    Klin Khir (1962); 1969 Apr; 4():26-31. PubMed ID: 5372189
    [No Abstract]   [Full Text] [Related]  

  • 60. [Results of conservative therapy of arterial circulatory disorders with gangrene].
    Heine H; Schmidt H
    Z Gesamte Inn Med; 1966 Nov; 21(21):Suppl:273-4 f. PubMed ID: 5994733
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.